Literature DB >> 21969589

Cell culture model that mimics drusen formation and triggers complement activation associated with age-related macular degeneration.

Lincoln V Johnson1, David L Forest, Christopher D Banna, Carolyn M Radeke, Michelle A Maloney, Jane Hu, Christine N Spencer, Aimee M Walker, Marlene S Tsie, Dean Bok, Monte J Radeke, Don H Anderson.   

Abstract

We introduce a human retinal pigmented epithelial (RPE) cell-culture model that mimics several key aspects of early stage age-related macular degeneration (AMD). These include accumulation of sub-RPE deposits that contain molecular constituents of human drusen, and activation of complement leading to formation of deposit-associated terminal complement complexes. Abundant sub-RPE deposits that are rich in apolipoprotein E (APOE), a prominent drusen constituent, are formed by RPE cells grown on porous supports. Exposure to human serum results in selective, deposit-associated accumulation of additional known drusen components, including vitronectin, clusterin, and serum amyloid P, thus suggesting that specific protein-protein interactions contribute to the accretion of plasma proteins during drusen formation. Serum exposure also leads to complement activation, as evidenced by the generation of C5b-9 immunoreactive terminal complement complexes in association with APOE-containing deposits. Ultrastructural analyses reveal two morphologically distinct forms of deposits: One consisting of membrane-bounded multivesicular material, and the other of nonmembrane-bounded particle conglomerates. Collectively, these results suggest that drusen formation involves the accumulation of sub-RPE material rich in APOE, a prominent biosynthetic product of the RPE, which interacts with a select group of drusen-associated plasma proteins. Activation of the complement cascade appears to be mediated via the classical pathway by the binding of C1q to ligands in APOE-rich deposits, triggering direct activation of complement by C1q, deposition of terminal complement complexes and inflammatory sequelae. This model system will facilitate the analysis of molecular and cellular aspects of AMD pathogenesis, and the testing of new therapeutic agents for its treatment.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21969589      PMCID: PMC3215058          DOI: 10.1073/pnas.1109703108

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  52 in total

Review 1.  Structure and activation of the C1 complex of complement: unraveling the puzzle.

Authors:  Christine Gaboriaud; Nicole M Thielens; Lynn A Gregory; Véronique Rossi; Juan C Fontecilla-Camps; Gérard J Arlaud
Journal:  Trends Immunol       Date:  2004-07       Impact factor: 16.687

2.  Senile macular degeneration: a histopathologic study. 1977.

Authors:  W Richard Green; Samuel N Key
Journal:  Retina       Date:  2005 Jul-Aug       Impact factor: 4.256

3.  Ageing and degeneration in the macular region: a clinico-pathological study.

Authors:  S H Sarks
Journal:  Br J Ophthalmol       Date:  1976-05       Impact factor: 4.638

4.  Repetitive nonlethal oxidant injury to retinal pigment epithelium decreased extracellular matrix turnover in vitro and induced sub-RPE deposits in vivo.

Authors:  Maria E Marin-Castaño; Gary E Striker; Oscar Alcazar; Paola Catanuto; Diego G Espinosa-Heidmann; Scott W Cousins
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-09       Impact factor: 4.799

5.  The ultrastructure of drusen.

Authors:  T G Farkas; V Sylvester; D Archer
Journal:  Am J Ophthalmol       Date:  1971-06       Impact factor: 5.258

6.  Clinico-morphologic correlations of drusen of Bruch's membrane.

Authors:  R P Burns; L Feeney-Burns
Journal:  Trans Am Ophthalmol Soc       Date:  1980

7.  Secreted proteome profiling in human RPE cell cultures derived from donors with age related macular degeneration and age matched healthy donors.

Authors:  Eunkyung An; Xiaoning Lu; Jessica Flippin; Joseph M Devaney; Brian Halligan; Eric P Hoffman; Eric Hoffman; Nataly Strunnikova; Karl Csaky; Yetrib Hathout
Journal:  J Proteome Res       Date:  2006-10       Impact factor: 4.466

8.  Distribution of complement anaphylatoxin receptors and membrane-bound regulators in normal human retina.

Authors:  Susan D Vogt; Scott R Barnum; Christine A Curcio; Russell W Read
Journal:  Exp Eye Res       Date:  2006-06-09       Impact factor: 3.467

Review 9.  Complement proteins C1q and MBL are pattern recognition molecules that signal immediate and long-term protective immune functions.

Authors:  Suzanne S Bohlson; Deborah A Fraser; Andrea J Tenner
Journal:  Mol Immunol       Date:  2006-08-14       Impact factor: 4.407

10.  Modulation of Sub-RPE deposits in vitro: a potential model for age-related macular degeneration.

Authors:  Sepideh Amin; N H Victor Chong; Tracey A Bailey; Jinjun Zhang; Carlo Knupp; Michael E Cheetham; John Greenwood; Philip J Luthert
Journal:  Invest Ophthalmol Vis Sci       Date:  2004-05       Impact factor: 4.799

View more
  94 in total

1.  Matrix metalloproteinase activity creates pro-angiogenic environment in primary human retinal pigment epithelial cells exposed to complement.

Authors:  Mausumi Bandyopadhyay; Bärbel Rohrer
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-04-18       Impact factor: 4.799

2.  Complementing apolipoprotein secretion by cultured retinal pigment epithelium.

Authors:  Christine A Curcio
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-07       Impact factor: 11.205

Review 3.  Dry age-related macular degeneration: mechanisms, therapeutic targets, and imaging.

Authors:  Catherine Bowes Rickman; Sina Farsiu; Cynthia A Toth; Mikael Klingeborn
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-12-13       Impact factor: 4.799

4.  Human retinal pigment epithelial cells prefer proline as a nutrient and transport metabolic intermediates to the retinal side.

Authors:  Jennifer R Chao; Kaitlen Knight; Abbi L Engel; Connor Jankowski; Yekai Wang; Megan A Manson; Haiwei Gu; Danijel Djukovic; Daniel Raftery; James B Hurley; Jianhai Du
Journal:  J Biol Chem       Date:  2017-06-14       Impact factor: 5.157

5.  Subcellular distribution and activity of mechanistic target of rapamycin in aged retinal pigment epithelium.

Authors:  Bo Yu; Pei Xu; Zhenyang Zhao; Jiyang Cai; Paul Sternberg; Yan Chen
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-12-09       Impact factor: 4.799

6.  Directional ABCA1-mediated cholesterol efflux and apoB-lipoprotein secretion in the retinal pigment epithelium.

Authors:  Nicholas N Lyssenko; Naqi Haider; Antonino Picataggi; Eleonora Cipollari; Wanzhen Jiao; Michael C Phillips; Daniel J Rader; Venkata Ramana Murthy Chavali
Journal:  J Lipid Res       Date:  2018-08-03       Impact factor: 5.922

7.  Clusterin and complement activation in exfoliation glaucoma.

Authors:  Ivo Doudevski; Agueda Rostagno; Mary Cowman; Jeffrey Liebmann; Robert Ritch; Jorge Ghiso
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-04-17       Impact factor: 4.799

8.  Bisretinoid-mediated complement activation on retinal pigment epithelial cells is dependent on complement factor H haplotype.

Authors:  Roxana A Radu; Jane Hu; Zhichun Jiang; Dean Bok
Journal:  J Biol Chem       Date:  2014-02-18       Impact factor: 5.157

Review 9.  Complement activation and choriocapillaris loss in early AMD: implications for pathophysiology and therapy.

Authors:  S Scott Whitmore; Elliott H Sohn; Kathleen R Chirco; Arlene V Drack; Edwin M Stone; Budd A Tucker; Robert F Mullins
Journal:  Prog Retin Eye Res       Date:  2014-12-05       Impact factor: 21.198

10.  Oxidative stress sensitizes retinal pigmented epithelial (RPE) cells to complement-mediated injury in a natural antibody-, lectin pathway-, and phospholipid epitope-dependent manner.

Authors:  Kusumam Joseph; Liudmila Kulik; Beth Coughlin; Kannan Kunchithapautham; Mausumi Bandyopadhyay; Steffen Thiel; Nicole M Thielens; V Michael Holers; Bärbel Rohrer
Journal:  J Biol Chem       Date:  2013-03-14       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.